Der Hautarzt

, Volume 56, Issue 5, pp 483–502

Einsatz von Phytopharmaka in der Dermatologie

Indikationen, Therapiehinweise und Nebenwirkungen
Weiterbildung · Zertifizierte Fortbildung

Zusammenfassung

In den letzten Jahren ist das Interesse an pflanzlichen Wirkstoffen und Arzneimitteln hinsichtlich ihrer Einsatzmöglichkeiten zur Behandlung von Hautkrankheiten stark gestiegen. Seitens der durch das deutsche Gesundheitsministerium berufenen Kommission E wurden (1987–1995) sog. Positivmonographien für die Anwendung bestimmter Phytopharmaka u. a. für diverse dermatologische Indikationen erstellt. Im Rahmen dieses Fortbildungsartikels werden unter besonderer Berücksichtigung pharmakologischer Grundlagen und Wirksamkeitsstudien phytotherapeutische Behandlungsmöglichkeiten von Hauterkrankungen durch ausgewählte Arzneipflanzen mit dermatologischer Positivmonographie aufgezeigt und der therapeutische Einsatz einiger „Modepflanzen“ diskutiert. Dermatologische Indikationen, Therapiehinweise und Angaben zu Rezepturen, Fertigarzneimitteln sowie mögliche Nebenwirkungen verschiedener Arzneipflanzen und ihr Potenzial zur Induktion sog. Phytodermatitiden werden im Einzelnen erläutert.

Schlüsselwörter

Phytotherapie Hauterkrankungen Positivmonographien Kommission E Phytodermatitiden 

Use of phytopharmaceutical agents in dermatology

Indications, therapeutic approaches and side effects

Abstract

In the recent years there has been increasing interest in herbal therapy including its use for treatment of dermatologic disorders. In Germany, a regulatory authority known as “Commission E” performed an extensive review of common phytotherapeutic (1987–1995) agents indicating quality of evidence, clinical efficacy and therapeutic usefulness producing a “positive monograph” indicating agents supported by evidence and likely to be useful. This article explores the therapeutic use of several of these and other currently popular plants suitable for dermatologic indications; therapeutic hints including phytotherapeutic products and formulations are given and side effects, in particular toxic and allergic skin reactions, are discussed.

Keywords

Phytotherapy Skin diseases Commission E Positive monography Phytodermatitis 

Literatur

  1. 1.
    Aertgeerts P, Albring M, Klaschka F et al. (1985) Comparative testing of Kamillosan cream and steroidal (0.25% hydrocortisone, 0.75% fluocortin butyl ester) and non-steroidal (5% bufexamac) dermatologic agents in maintenance therapy of eczematous diseases. Z Hautkr 60:270–277Google Scholar
  2. 2.
    Albring M, Albrecht H, Alcorn G, Lucker PW (1983) The measuring of the antiinflammatory effect of a compound on the skin of volunteers. Methods Find Exp Clin Pharmacol 5:575–577Google Scholar
  3. 3.
    Bassett IB, Pannowitz DL, Barnetson RS (1990) A comparative study of tea-tree oil versus benzoylperoxide in the treatment of acne. Med J Aust 153:455–458Google Scholar
  4. 4.
    Braun H, Frohne D (1994) Heilpflanzenlexikon. Wirkungen, Verordnungen, Selbstmedikation. Gustav Fischer, StuttgartGoogle Scholar
  5. 5.
    Buck DS, Nidorf DM, Addino JG (1994) Comparison of two topical preparations for the treatment of onychomycosis: Melaleuca alternifolia (tea tree) oil and clotrimazole. J Fam Pract 38:601–605Google Scholar
  6. 6.
    Diehm C, Trampisch HJ, Lange S, Schmidt C (1996) Comparison of leg compression stocking and oral horse-chestnut seed extract therapy in patients with chronic venous insufficiency. Lancet 347:292–294Google Scholar
  7. 7.
    Eggermont AM, Kleeberg UR, Ruiter DJ, Suciu S (2001) European Organization for Research and Treatment of Cancer Melanoma Group. Trial experience with more than 2,000 patients, evaluating adjuvant treatment with low or intermediate doses of interferon alpha-2b. In: Perry MC (ed) American Society of Clinical Oncology. Educational Book (37th Annual Meeting). Alexandria, pp 88–93Google Scholar
  8. 8.
    Ellis CN, Berberian B, Sulica VI et al. (1993) A double-blind evaluation of topical capsaicin in pruritic psoriasis. J Am Acad Dermatol 29:438–442Google Scholar
  9. 9.
    Ernst E, Huntley A (2000) Tea tree oil: a systematic review of randomized clinical trials. Forsch Komplementarmed Klass Naturheilkd 7:17–20Google Scholar
  10. 10.
    Hammer KA, Carson CF, Riley TV (2002) In vitro activity of Melaleuca alternifolia (tea tree) oil against dermatophytes and other filamentous fungi. J Antimicrob Chemother 50:195–199Google Scholar
  11. 11.
    Hausen BM, Busker E, Carle R (1984) The sensitizing capacity of composite plants. VII. Experimental studies with extracts and compounds of Chamomilla recutita (L.) Rauschert and Anthemis cotula L. Planta Med 50:229–234Google Scholar
  12. 12.
    Heggers JP, Robson MC, Manavalen K et al. (1987) Experimental and clinical observations on frostbite. Ann Emerg Med 16:1056–1062Google Scholar
  13. 13.
    Knuesel O, Weber M, Suter A (2002) Arnica montana gel in osteoarthritis of the knee: an open, multicenter clinical trial. Adv Ther 19:209–218Google Scholar
  14. 14.
    Korting HC, Schafer-Korting M, Klovekorn W et al. (1995) Comparative efficacy of hamamelis distillate and hydrocortisone cream in atopic eczema. Eur J Clin Pharmacol 48:461–465Google Scholar
  15. 15.
    Kurkcuoglu N, Alaybeyi F (1990) Topical capsaicin for psoriasis. Br J Dermatol 123:549–550Google Scholar
  16. 16.
    Lacey CJ, Goodall RL, Tennvall GR et al. (2003) Randomised controlled trial and economic evaluation of podophyllotoxin solution, podophyllotoxin cream, and podophyllin in the treatment of genital warts. Sex Transm Infect 79:270–275Google Scholar
  17. 17.
    Maiche AG, Grohn P, Maki-Hokkonen H (1991) Effect of chamomile cream and almond ointment on acute radiation skin reaction. Acta Oncol 30:395–396Google Scholar
  18. 18.
    McCauley RL, Heggers JP, Robson MC (1990) Frostbite. Methods to minimize tissue loss. Postgrad Med 88:67–77Google Scholar
  19. 19.
    Munn SE, Burrows NP, Abadia-Molina F et al. (1997) The effect of topical capsaicin on substance P immunoreactivity: a clinical trial and immunohistochemical analysis. Acta Derm Venereol 77:158–159Google Scholar
  20. 20.
    Niedner R (1996) Solanum dulcamara L. — ein „Pflanzen-Cortison“? Med Monatsschr Pharm 19:339–340Google Scholar
  21. 21.
    Nissen HP, Biltz H, Kreysel HW (1988) Profilometrie, eine Methode zur Beurteilung der therapeutischen Wirsamkeit von Kamillosan®-Salbe. Z Hautkr 63:184–190Google Scholar
  22. 22.
    Oestreich W (1995) Topische Ekzemtherapie mit einem Phytopharmakon — eine multizentische Studie. Hautnah Derm 11:184–189Google Scholar
  23. 23.
    Patzelt-Wenczler R, Ponce-Poschl E (2000) Proof of efficacy of Kamillosan(R) cream in atopic eczema. Eur J Med Res 5:171–175Google Scholar
  24. 24.
    Paulsen E (2002) Contact sensitization from Compositae-containing herbal remedies and cosmetics. Contact Dermatitis 47:189–198Google Scholar
  25. 25.
    Pommier P, Gomez F, Sunyach MP et al. (2004) Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. J Clin Oncol 22:1447–1453Google Scholar
  26. 26.
    Reider N, Komericki P, Hausen BM et al. (2001) The seamy side of natural medicines: contact sensitization to arnica (Arnica montana L.) and marigold (Calendula officinalis L.). Contact Dermatitis 45:269–272Google Scholar
  27. 27.
    Ribereau-Gayon G, Jung ML, Frantz M, Anton R (1997) Modulation of cytotoxicity and enhancement of cytokine release induced by Viscum album or misteltoe lectins. Anticancer Drugs, pp 3–8Google Scholar
  28. 28.
    Syed TA, Ahmad SA, Holt AH et al. (1996) Management of psoriasis with Aloe vera extract in a hydrophilic cream: a placebo-controlled, double-blind study. Trop Med Int Health 1:505–509Google Scholar
  29. 29.
    Szeimies RM, Stolz W, Wlotzke U et al. (1994) Successful treatment of hydroxyethyl starch-induced pruritus with topical capsaicin. Br J Dermatol 131:380–382Google Scholar
  30. 30.
    Tarng DC, Cho YL, Liu HN, Huang TP (1996) Hemodialysis-related pruritus: a double-blind, placebo-controlled, crossover study of capsaicin 0.025% cream. Nephron 72:617–622Google Scholar
  31. 31.
    Thomas DR, Goode PS, LaMaster K, Tennyson T (1998) Acemannan hydrogel dressing versus saline dressing for pressure ulcers. A randomized, controlled trial. Adv Wound Care 11:273–276Google Scholar
  32. 32.
    Tupker RA, Coenraads PJ, van der Meer JB (1992) Treatment of prurigo nodularis, chronic prurigo and neurodermatitis circumscripta with topical capsaicin. Acta Derm Venereol 72:463Google Scholar
  33. 33.
    Vazquez JA (2002) Efficacy of alcohol-based and alcohol-free melaleuca oral solution for the treatment of fluconazole-refractory oropharyngeal candidiasis in patients with AIDS. HIV Clin Trials 3:379–385Google Scholar
  34. 34.
    Wallengren J (1991) Treatment of notalgia paresthetica with topical capsaicin. J Am Acad Dermatol 24:286–288Google Scholar
  35. 35.
    Wallengren J, Klinker M (1995) Successful treatment of notalgia paresthetica with topical capsaicin: vehicle-controlled, double-blind, crossover study. J Am Acad Dermatol 32:287–289Google Scholar
  36. 36.
    Weber K, Mengs U, Schwarz T et al. (1998) Effects of a standardized mistletoe preparation on metastatic B16 melanoma colonization in murine lungs. Arzneimittelforschung 48:497–502Google Scholar
  37. 37.
    Wenigmann M (1999) Phytotherapie — Arzneipflanzen, Wirkstoffe, Anwendungen. Urban & Fischer, MünchenGoogle Scholar
  38. 38.
    Willital GH, Heine H (1994) Efficacy of Contractubex gel in the treatment of fresh scars after thoracic surgery in children and adolescents. Int J Clin Pharmacol Res 14:193–202Google Scholar

Copyright information

© Springer Medizin Verlag 2005

Authors and Affiliations

  1. 1.Klinik und Poliklinik für Dermatologie der Universität Regensburg
  2. 2.Klinik und Poliklinik für DermatologieUniversität RegensburgRegensburg

Personalised recommendations